SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-20-180810
Filing Date
2020-06-26
Accepted
2020-06-26 15:27:03
Documents
2
Group Members
ANSBERT GADICKELUKE EVNINMPM ASSET MANAGEMENT INVESTORS BV5 LLCMPM BIOVENTURES V GP LLCMPM BIOVENTURES V LLCTODD FOLEY

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d30359dsc13da.htm SC 13D/A 170865
2 EX-99.A d30359dex99a.htm EX-99.A 8160
  Complete submission text file 0001193125-20-180810.txt   180911
Mailing Address MPM ASSET MANAGEMENT 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116
Business Address MPM ASSET MANAGEMENT 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116 (617) 425-9200
MPM BIOVENTURES V, L.P. (Filed by) CIK: 0001482716 (see all company filings)

IRS No.: 270793842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Subject) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90134 | Film No.: 20993774
SIC: 2834 Pharmaceutical Preparations